Latest papers

[Echocardiography of left ventricular mass in patients with essential hypertension].

Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.

The effects of perindopril on aortic elasticity and inflammatory markers in hypertensive patients.

[Effects of perindopril and spirolactone on plasma aldosterone and left atrial remodeling in a canine model of atrial fibrillation].

Mixed models showed no need for initial response monitoring after starting antihypertensive therapy.

Protection of patients with diabetes, with or without hypertension: implications of ADVANCE for clinical practice.

Heart protection: a key target in the management of patients with diabetes.

A case of Parkinson's disease worsened by captopril: an unexpected adverse effect.

[Fixed combination perindopril-amlodipine (Coveram) in the treatment of hypertension and coronary heart disease].

Cardiovascular outcomes and angiotensin converting enzyme inhibitors: beyond blood pressure control. Editorial to: "Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?" by Remme et al.

Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.

Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.

Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.

[Hypotensive and metabolic effect of indapamide and perindopril in patients with type 2 diabetes and arterial hypertensia].

Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.

Controversy in treating the oldest old with hypertension: is the hypertension in the very elderly trial the final answer?

[The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension]

An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.

[Innovations in ambulatory care].